Swiss pharmaceutical giant Novartis has raised its full-year earnings forecast, citing robust revenue growth from key products, including its breast cancer drug Kisqali, during a strong second quarter. The company also announced a substantial share buyback program, signaling confidence in its future growth trajectory, alongside news of its long-serving Chief…
European stock markets are set to open higher on Thursday, with positive momentum fueled by a strong earnings report…
Volvo Cars has reported a group operating profit (EBIT) of SEK -10.0 billion for the second quarter of 2025,…
As crypto becomes part of our day-to-day financial needs, Thailand is introducing a national sandbox to allow foreign tourists…
A quiet town in Maharashtra found itself in an international spotlight this week.Kolhapur, famed for its traditional leather chappals…
Shares of PepsiCo Inc. climbed in premarket trading on Thursday after the snack and beverage giant reported a better-than-expected…
Asian stock markets began Wednesday’s trading session on a weaker footing, with most regional indices declining as investors reacted…
In the hallowed halls of Cupertino, a revolution is taking shape. Apple, the world’s most influential smartphone brand, is…
BHP, a major mining company, has stated that establishing a “green iron” industry in Australia is cost-prohibitive, Reuters said…